/
Oncology
Thyroid Cancer
69
Pipeline Programs↗
114
Active Trials↗
44
Companies Involved↗
Thyroid Cancer is a moderately active landscape with 69 programs across 44 companies. The most active players are Eli Lilly, AffyImmune Therapeutics, Inc., AstraZeneca. 10 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical25
Phase 17
Phase 227
Phase 310
Approved
No programs
Analysis
Modality Breakdown
85%
Small molecule
57 of 67 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 67 classified programs, each share of the total. Modality classified for 97% of 69 pipeline programs.
Analysis
Trial Status
331
clinical trials
Completed139 · 42%
Recruiting59 · 18%
Unknown status36 · 11%
Active, not recruiting32 · 10%
Terminated25 · 8%
Not yet recruiting20 · 6%
Other20 · 6%
Clinical Trials
Trial Activity
331 trials
Caratterizzazione Del Profilo Mutazionale Nel Tumore Papillare Della Tiroide Tramite Tecnologia Mass-ARRAY
Recruiting·—·N/A·NCT05766098·600 enrolled
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
Recruiting·National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)·Phase 2·NCT04927416·54 enrolled
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
Recruiting·National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)·Phase 2·NCT03841617·30 enrolled
Studies on Thyroid Nodules and Thyroid Cancer
Recruiting·National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)·N/A·NCT00001160·2,500 enrolled
Clinical and Genetic Studies in Familial Non-Medullary Thyroid Cancer
Recruiting·National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)·N/A·NCT01109420·500 enrolled
Page 1 of 23
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)